Lord Sarfraz visited Singapore in his capacity as the Prime Minister's Trade Envoy. During his visit, he witnessed, alongside Singapore's Minister for Health, the launch of GSK's new High Potency Facility which produces a key ingredient, a cytotoxic component, in antibody drug conjugates (ADCs)
